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a  b  s  t  r  a  c  t
Introduction: Colorectal cancer, in Portugal, presents as the second most common cancer and
of  cancer death cause. CRC is a disease of the elderly; however, there has been an increase of
incidence in younger patients and doubts have emerged about its behavior, characteristics
and  prognosis in this group.
Methods: In this study, we have evaluated a sample of 512 patients diagnosed with colorectal
cancer submitted to surgical treatment in the period between January 1st, 2005 and Jan-
uary 1st, 2010, through a comparative clinical, pathological and survival analysis of patients
under and over 45 years old (Groups I and II respectively).
Results: Group I patients accounted for 5.5% of the sample. There was a predominance of
males and the most common site was the left colon in both age groups. In the younger group,
the  histological type presents with a predominance of tumors with a mucinous component
and with signet ring cells (p = 0.001), however, there was no difference in terms of overall
survival and disease-free survival.
Conclusion: In this study, colorectal cancer at younger ages shows similar characteristics to
those of older patients.© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This
is  an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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E-mail: sandramartins@ecsaude.uminho.pt (S.F. Martins).
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2237-9363/© 2016 Sociedade Brasileira de Coloproctologia. Published by Elsevier Editora Ltda. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Câncer  colorretal:  análise  comparativa  das  características  clínicas  e
anatomopatológicas  em  doentes  com  idade  superior  e  inferior  a  45  anos







r  e  s  u  m  o
Introduc¸ão: O Câncer Colorectal (CCR), em Portugal, constitui o segundo câncer mais fre-
quente em termos de incidência e de mortalidade. É uma doenc¸a do idoso, no entanto,
tem-se observado um aumento da incidência em pacientes mais jovens, tendo surgido
dúvidas acerca do seu comportamento, características e prognóstico neste grupo etário.
Métodos: 512 pacientes com diagnóstico de CCR operados entre Janeiro de 2005 e Janeiro
de  2010 foram avaliados através da análise comparativa das características clínicas, anato-
mopatológicas e sobrevida em indivíduos com idade inferior e superior a 45 anos (Grupo I e
II  respetivamente).
Resultados: Os pacientes do Grupo I representaram 5,5% da amostra. Houve predomínio
do  gênero masculino e o local mais frequente foi o cólon esquerdo em ambos os grupos.
No  grupo mais jovem, relativamente ao tipo histológico ocorreu predomínio signiﬁcativo
de  tumores com componente mucinoso e células em anel de sinete (p = 0,001), mas sem
diferenc¸a  ao nível da sobrevida global e sobrevida livre de doenc¸a.
Conclusão: Neste estudo, o CCR em idades mais jovens revelou características semelhantes
às dos pacientes mais idosos.
© 2016 Sociedade Brasileira de Coloproctologia. Publicado por Elsevier Editora Ltda. Este



























n recent decades, there has been an increasing prevalence
f cancers in the world.1,2 Colorectal cancer (CRC) is the most
ommon malignancy of the gastrointestinal tract3,4 and due to
he increased incidence and mortality that occurred in recent
ecades, and also to the costs that are associated with diag-
osis and treatment, this cancer has become a major public
ealth problem worldwide.5
Worldwide, CRC is the 3rd most common cancer and the
th leading cause of deaths by cancer; in 2008, 609,051 deaths
ccurred, 223,268 of them in Europe.3
About 95% of all CRCs arise from adenomatous polyps of
he intestinal mucosa, with increasing incidence with age;
owever, only 10% of adenomas will result in a CRC.6–9
The knowledge of the natural history of the disease and the
ossibility of intervening at an earlier stage led to the imple-
entation of screening programs, which currently cover the
opulation over 50 years with no risk factors for CRC.10,11
There are several risk factors that are associated with
he development of CRC, and some of them imply an ear-
ier screening.12–14 Age is one of the main risk factors for the
evelopment of CRC, with over 90% of cases occurring in indi-
iduals aged over 50 years, with a mean age of diagnosis of 65
ears.14–16 For this reason, CRC is considered a disease of the
lderly.
The population under 50 years and without risk factors is
xcluded from the screening group and is therefore some-
hat neglected, and this requires a high index of suspicion
y the physician for the establishment of a diagnosis of CRC.
lthough occurring less frequently, CRC is also diagnosed in
his age group, and there has been an increased incidencelicenses/by-nc-nd/4.0/).
among these people, a fact that cannot be ignored.17–19 Pre-
vious studies describe a wide variation of this frequency, with
values from 1.3% to 37%, and the highest values are found in
the Asian population.19–27 This issue has aroused great inter-
est in the medical literature, though with controversial results,
and many  studies have been conducted in order to evalu-
ate possible differences in behavior and prognosis of CRC in
young people compared with the general population with this
cancer. Most authors argue that young age is associated with
more  advanced stages of the disease at diagnosis and with
more  aggressive histopathologic characteristics, for example,
a lower degree of differentiation and mucin secretion.19,23,24
Some authors still describe a worse prognosis in this group.26
However, other studies contradict these ﬁndings, describing
results similar to those of patients with a later diagnosis, or
even with improvement in their survival.21,22,27
Taking into account the controversy on this subject and the
lack of studies in Portugal, this project was carried out in order
to make a comparative analysis of the clinical and pathological
characteristics of patients with CRC diagnosed with ages over
and under 45 years, and to evaluate the possible impact of the
age factor in its prognosis.
Methods
The population included in this study consists of patients with
a diagnosis of CRC who underwent surgery in the period from
January 1, 2005, to January 1, 2010, in the Braga Hospital (BH).In our study, the following inclusion criteria were: patients
with histologically conﬁrmed CRC who underwent surgical
resection with curative intent.
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Exclusion criteria were: patients with inﬂammatory bowel
disease (IBD), namely Crohn’s disease and ulcerative colitis;
patients with hereditary syndromes such as familial adeno-
matous polyposis (FAP) and hereditary colorectal cancer not
associated with polyposis (HCCNP); patients with no primary
disease of the colon or rectum; patients diagnosed with CRC
but who did not undergo surgery, and patients with CRC under-
going non-curative surgical treatment.
The exclusion of patients with hereditary syndromes was
performed after conﬁrmed by genetic studies in patients for
whom there was a clinical suspicion.
To collect information, a prospective database of CRC was
surveyed, and the following data were collected:
Clinical  data  and  preoperative  tests
Information concerning the age, gender, clinical presentation,
tumor location and the presence of metastasis was evaluated.
Regarding age, the patients were grouped into age under or
equal to 45 years (Group I) and more  than 45 years (Group II).
Pathological  data
The parameters evaluated included tumor size, macroscopic
appearance of the tumor, histologic type, tumor extension
(pT), tálus degree of differentiation, the presence of lymph
node metastases (pN), presence of venous and lymphatic inva-
sion, and staging.
The staging was carried out according to the TNM classi-
ﬁcation of the American Joint Committee on Cancer (AJCC),
Sixth Edition.28
Follow-up
The patients were monitored regularly.
The follow-up of patients with CRC is subdivided into three
periods: 1st and 2nd year, 3rd to 5th year, and from 6th year
postoperatively. Thus, in the 1st and 2nd years, the patients
are evaluated in quarterly consultations; from 3rd to 5th year,
the assessment becomes biannual, and after 5 years, the
patient is evaluated annually. In these consultations, besides
patient observation, tumor markers (CEA and CA19-9) are also
accessed, and an annual chest X-ray is obtained.
Regarding colonoscopy, the procedure is performed within
one year after surgical resection (or 3–6 months after surgery,
if the colonoscopy was not performed pre- or transopera-
tively due to an obstructive lesion) with repetition 3 years
after surgery; subsequently, a colonoscopy is obtained every
5 years, unless a follow-up colonoscopy reveals evidence of an
advanced adenoma (villous polyp, polyp >1 cm,  or high-grade
dysplasia). In this case, the colonoscopy should be repeated 1
year after polypectomy.
Regarding the realization of computerized axial tomogra-
phy, this procedure is performed annually in the ﬁrst three
years after surgery, or whenever symptoms or an increase of
tumor markers warrant this procedure. In the case of rectal
cancer, a pelvic NMR  is also performed 6 months postopera-
tively, which will remain as reference NMR.
The moment of diagnosis was used as starting point for
survival analysis. In the case of overall survival, this was 1 6;3  6(4):196–202
calculated until the patient’s death for any reason, and
disease-free survival was considered as the time elapsed until
the occurrence of a relapse. Both indicators were evaluated
until August 31, 2012.
Statistical  analysis
The Statistical Package for Social Sciences for Windows (SPSS
version 19.0.0, SPSS Inc.) was used in the database analysis.
Statistical comparisons between groups were performed
using the Pearson’s chi-squared test (X2) whenever possible,
and the Fisher’s exact test (values <5).
Overall survival and disease-free survival curves were cal-
culated using the Kaplan–Meier method, and the comparison
between the two groups was performed using the log-rank
test.
p-values <0.05 were considered statistically signiﬁcant.
This study was submitted to, and approved by, the Braga
Hospital Ethics Committee.
Results
In the period between January 1, 2005, and January 1, 2010, 672
patients with CRC were diagnosed in BH; 512 patients met  the
criteria previously described.
Group I accounted for 5.5% (n = 28) of the sample and Group
II for 94.5% (n = 484). In both groups a predominance of males
was noted: 67.86% (n = 19) for Group I and 61.98% (n = 300) for
Group II, with no statistically signiﬁcant difference (p = 0.533).
Most patients in both groups had symptoms at the moment of
diagnosis (92.86%, n = 26 and 81.2%, n = 393, respectively). The
most common site was the left colon, with a total of 48.44%
of cases (n = 248) followed by the rectum with 28.13% (n = 144)
and the right colon with 23.44% (n = 120). Comparing the site
by age group, we found similar results.
At diagnosis, we found that 32.19% (n = 9) and 20.04%
(n = 97), respectively, had metastases. As to the variables stud-
ied, no signiﬁcant differences were observed between groups
(Table 1).
A slightly higher frequency was observed in patients with
CRCs ≤45 mm,  occurring in 57.62% (n = 295) of cases. In the
analysis by age group, it was found that CRCs ≤45 mm
accounted for 50% (n = 14) of Group I and 58.06% (n = 281) of
Group II. The polypoid type predominated both in Group I and
Group II, representing 60.71% (n = 17) and 50.41% (n = 244) of
cases, respectively, followed by the ulcerative type. The inﬁl-
trative type stood as the third most frequent type in Group II
(8.40%) and as the fourth type in Group I (3.57%); in the lat-
ter group, the third place was taken by the exophytic type
(10.71%). The villous type was the rarest of all, being repre-
sented only in Group II (n = 2). Regarding histological type, the
most common type was adenocarcinoma in 93.36% (n = 478) of
cases, followed by the mucinous type in 10.55% (n = 54) of cases
and by signet ring cell/mucinous area type in 0.78% (n = 4).
Mucinous type and signet ring cell/mucinous area type were
statistically more  frequent in Group I, with 14.29% (n = 4) and
7.14% (n = 2) respectively, versus 10.33% (n = 50) and 0.41% (n = 2)
in Group II (p = 0.001). “Well-differentiated” was the predomi-
nant degree of tumor differentiation in the sample, occurring
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Table 1 – Distribution of variables related to clinical and
preoperative test data, according to the age group, in the
sample under study.
Group I Group II pa
% (n) % (n)
Age 5.5% (28) 94.5% (484)
Gender
Male 67.86% (19) 61.98% (300) 0.533
Female 32.14% (9) 38.02% (184)
Clinical presentation
Symptomatic 92.86% (26) 81.2% (393) 0.137
Asymptomatic 7.14% (2) 18.8% (91)
Location
Right colon 28.57%(8) 23.14%(112)
Left colon 46.43%(13) 48.55%(235) 0.794
Rectum 25%(7) 28.31%(137)
Metastases
Absent 67.86%(19) 79.96(387) 0.124


































Table 2 – Distribution of variables related to pathological








≤45 mm 50% (14) 58.06% (281) 0.963
>45 mm 32.14 (9) 36.57% (177)
Macroscopic aspect
Polypoid 60.71% (17) 50.41% (244)
Ulcerative 14.29% (4) 23.97% (116) 0.588
Inﬁltrative 3.57% (1) 8.68% (42)
Exophytic 10.71% (3) 8.06% (39)
Villous 0.0% (0) 0.41% (2)
Histological type
Adenocarcinoma 78.57(22) 88.26 (432)
Mucinous 14.29 (4) 10.33 (50) 0.001
Signet ring cells 7.14 (2) 0.41 (2)
Differentiation
Well differentiated 32.14% (9) 44.63% (216)
Moderately differentiated 42.86% (12) 41.53% (201) 0.337
Poorly differentiated 18% (5) 9.09% (44)
Undifferentiated 0.0 (0) 0.83% (4)
Ganglionic metastases
Absent 42.86% (12) 56.61% (274) 0.153
Present 53.57% (15) 40.29% (195)
Venous invasion
Absent 46.43%(13) 53.72% (260) 0.394
Present 50.0%(14) 41.32% (200)
Lymphatic invasion
Absent 39.29% (11) 41.32% (200) 0.699
Present 57.14% (16) 51.45% (249)
Stage
I 7.14% (2) 15.5% (75)
II 28.57% (8) 36.98% (179) 0.224
III 35.71% (10) 30.99% (150)
IV 28.57% (8) 14.05% (68)























80 100a Calculated by Fisher’s exact test.
n 43.95% (n = 225) of cases. The smaller the differentiation,
he lower the frequency. However, in Group I, the most fre-
uent category was that of “moderately differentiated” tumor,
ccurring in 42.86% (n = 12) of cases. It was also found in this
roup that well-differentiated grade was less frequent; poorly
ifferentiated grade was more  often seen, with 32.14% (n = 9)
nd 18% (n = 5), respectively, compared to Group II, with 44.63%
n = 216) and 9.09% (n = 44), respectively.
In this group, we  also found a lower frequency of well dif-
erentiated grade tumors and a higher frequency of poorly
ifferentiated grade tumors, with 32.14% (n = 9) and 18% (n = 5),
espectively, compared to group II, with 44.63% (n = 216) and
.09% (n = 44), respectively.
In Group I, there were more  patients with the presence
53.57%) versus absence (42.86%) of nodal metastases; On the
ther hand, the opposite occurred in Group II, with 40.29%
nd 56.61%, respectively. The venous invasion occurred more
ften in Group I, 50% of cases, as opposed to Group II, 41.32%.
n both age groups, the presence of lymphatic invasion pre-
ailed, 57.14% and 52.45% respectively. As for staging, the
tages II, III and IV were the most frequent in the sample,
ith 28.57% (n = 8) 35.71% (n = 10) and 28.57% (n = 8) patients,
espectively, in Group I and 36.98% (n = 179), 35.71% (n = 10)
nd 30.99% (n = 150), respectively, in Group II. Comparing the
wo age groups, a higher frequency of stages III and IV was
oted in Group I. For the several variables studied, signiﬁ-
ant differences between groups were not observed, except
or histological type (Table 2).
The follow-up time ranged from 2 to 7 years. Overall sur-
ival was 63%, with a median survival of approximately 63 ± 2
onths (Fig. 1).
Group I showed a 5-year overall survival of 61% and a
edian survival of approximately 58 ± 6 months. In Group II,
-year overall survival was 63% and the median survival was
pproximately 63 ± 2 months (Fig. 2). There was no statistically
igniﬁcant difference between groups with respect to survival
p = 0.738).
Fig. 1 – Cumulative overall survival in the study sample.























































Fig. 4 – Disease-free survival by age group in the sample
sample under study. Calculated by Log-Rank test. p = 0.738.
Survival curves were estimated by the TNM staging system;
it was found that the more  advanced the stage at diagnosis,
the lower the 5-year overall survival, with 91% in stage I, 70% in
stage II, 56% in stage III and 33% in stage IV. Five-year survival
on stage I was 100% in Group I and 91% in Group II; on stage II,
88% and 69%, respectively; on stage III, 70% and 55%, respec-
tively; and on stage IV, 13% and 36%, respectively. Comparing
the two age groups, we  found a better survival in Group I for
those cases in which the diagnosis was established in stages
I, II and III, and a worse survival in stage IV. However, these
differences were not statistically signiﬁcant, despite the trend
observed for stage IV (stage I: p = 0.659, stage II: p = 0.252; stage
III: p = 0.504; stage IV: p = 0.061). In the study sample, the 5-year
disease-free survival was approximately 86%, with a mean of
83 ± 1 month (Fig. 3). In Group I there was a 5-year disease-free
survival of 81%, with a mean of 82 ± 3 months, a slightly lower
result versus Group II, in which this parameter was 86% with
a mean of 83 ± 1 months, but without statistically signiﬁcant

























Fig. 3 – Disease-free survival in the sample under study.under study. *Calculated by Log-Rank test.
Discussion
CRC is a disease of the elderly, occurring more  frequently
in the sixth and seventh decades of life, although it was
observed increased incidence in younger individuals in recent
decades.17–19 In the literature, the impact of “age” in the prog-
nosis of patients with CRC is an object of controversy and
has been the subject of much interest and research. Taken
into account that there are no data on the Portuguese reality,
this study sought to better understand this issue in patients
treated at the Braga Hospital, through an analysis of clinical
and pathological characteristics of CRC in patients divided into
two age groups, and the assessment of the impact of this factor
on survival.
It was found that 5.5% of patients were aged 45 years or
younger (Group I), which is consistent with the values found
in the literature. Male gender was the most frequent in this
study, both in the total sample and in age groups, which is
in line with the general distribution of gender in those cases
of CRC described by GLOBOCAN 2008,3 and in some studies
based on young populations,21,23 with no statistical difference
regarding this parameter. Other studies based on young people
describe an equal distribution between genders.19,24,26
In both groups, the presence of symptoms prevailed at diag-
nosis, indicating that the correct valuation and assessment of
symptoms through additional tests to an accurate establish-
ment of the diagnosis is essential for the diagnosis of CRC,
regardless of age. These results are in agreement with those
found by other studies.27
The sites most commonly affected by CRC are sigmoid
colon and rectum,19,21,27 which is in line with our results, in
which left colon predominance was noted in both groups.
Tumors with size ≤45 mm occurred in greater numbers and
the macroscopic appearance more  often seen was the poly-
poid type in both groups; these parameters are no subject of
difference between age groups.
In patients with CRC, adenocarcinoma is the most common
histological type,29 as we found in this study. With respect to
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ucinous and signet ring cell/mucinous area types, a statisti-
ally signiﬁcant difference was noted; these latter types were
ore  often seen in Group I (p = 0.001), as already mentioned
y other authors.19,24,26 Despite the description of these histo-
ogical types in association with a worse prognosis,30 this was
ot the case in this study, and the overall survival was similar
n both groups.
Several studies have reported lower differentiation grades
n younger patients, which would characterize CRC in this
roup as a more  aggressive tumor;19,24 however, other studies
ontradicting these ﬁndings were published.21,27 In our study,
he degree found more  frequently was the moderately dif-
erentiated; in Group I, a well-differentiated grade was found
ess frequently, and poorly differentiated grade was the most
revalent, although without statistical difference between
roups. This ﬁnding shows that CRC in younger patients does
ot show more  aggressiveness.
The presence of venous and lymphatic invasion was similar
n both groups. The venous invasion occurred in about half the
ases, and lymphatic invasion occurred in greater proportion,
ontributing to a more  advanced stage in the sample, which
grees with results from other studies.21,27
Several authors describe the presence of a more  advanced
isease at diagnosis in younger patients.24,26 In this sample,
dvanced stages were more  frequent, reﬂecting the insidious
nd usually silent (or with few symptoms) nature of this dis-
ase, which results in delayed diagnoses. Despite the slight
redominance of stages III and IV in Group I, there was no
tatistical difference; and the results were equivalent to those
f Group II. Most CRCs were seen in stage T3, nodal metastases
ere present in about 41% of the sample, and metastases at
iagnosis were uncommon, but for none of these variables a
tatistical difference was observed, conﬁrming that the stage
s similar in both age groups. Some studies have conﬁrmed the
esults of this study with respect to the stage.19,21,27,29
Some authors report a lower survival rate26 in younger
atients; however, most of the recently published studies have
ound opposite results.19,21,22,24,27 In this study, there were
o signiﬁcant differences in overall survival and disease-free
urvival. In group I, in patients aged 45 years or less the over-
ll survival was 61% and the disease-free survival was 81%
 values similar to those found in Group II. These ﬁndings
emonstrate that a diagnosis in younger patients is not asso-
iated with a worse prognosis.
Survival depends largely on the stage at diagnosis: the more
dvanced the stage, the worse the survival, with values of 91%,
0%, 56% and 33% for stages I, II, III and IV, respectively, which
grees with the values found in the literature.
onclusion
n this study, it was found that several clinical and patho-
ogical parameters evaluated were very similar in both age
roups analyzed, and an increased incidence of tumors with
ucinous and signet ring components were found in Group I;
owever, these ﬁndings did not impact on the level of survival.
It is essential that health professionals are aware of this
iagnosis, even in patients at younger ages; It should also be
mphasized the importance of health promotion campaigns;3 6(4):196–202 201
to change habits and lifestyles, and to disease prevention with
screening programs, in order to achieve a reduction in the
incidence and mortality associated with this disease.
We believe that this study is only a preliminary assessment
of the impact of the age factor on the survival of patients with
CRC. Taking into account that this is a study of patients from
only one hospital, it would be important to extend it to other
centers as well as to increase the follow-up period, to better
know the Portuguese reality.
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